Abstract
The aim of this prospective study was to assess glomerular and tubular renal function before, and 1 and 2 years after hematological stem cell therapy (HSCT) in children and adolescents. 137 consecutive patients undergoing HSCT, for malignant diseases, were included in a prospective trial. Forty-four patients were followed for up to 1 year after HSCT and 36 for up to 2 years, without relapse. Ninety healthy school children were used as a control group. The following parameters were investigated: inulin clearance (GFR), urinary excretion of albumin, α1-microglobulin (α1-MG), calcium, β-N-acetylglucosaminidase (β-NAG) and Tamm–Horsfall protein (THP), tubular phosphate reabsorption (TP/Clcr) and percent reabsorption of amino acids (TAA). Significantly lower GFR was found 1 and 2 years after HSCT but within the normal range in the period before HSCT. There was no correlation between GFR within the first month after HSCT and long-term outcome of GFR. Tubular dysfunction was found in 14–45% of patients 1 and 2 years after HSCT depending on the parameter investigated. Pathological values 1 and 2 years after HSCT were found for α1-MG excretion in 40% and 39%, respectively, for TP/Clcr in 44% and 45%, for β-NAG in 26% and 19%. Median TP/Clcr was significantly lower 2 years after HSCT than before. TAA was mildly impaired in 7/14 patients before, in 5/29 one and in 9/29 2 years after HSCT, but median TAA was within normal range at all times. The median excretion of albumin, THP and calcium was within the normal range at all investigations. No influence of ifosfamide pre-treatment on the severity of tubulopathy was found. The investigation of tubular renal function should be part of a long-term follow-up in children after HSCT. Bone Marrow Transplantation (2001) 27, 319–327.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Donckerwolcke RA, Coppes MJ . Cytotoxic treatment and alterations in kidney function Med Pediatr Oncol 1998 30: 178–179
Rossi R, Kleta R, Ehrich JH . Renal involvement in children with malignancies Ped Nephrol 1999 13: 153–162
Fink JC, Cooper MA, Burkhart KM et al. Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced ‘hepatorenal syndrome’ J Am Soc Nephrol 1995 6: 1655–1660
Lane PH, Mauer SM, Blazar BR et al. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients Bone Marrow Transplant 1994 13: 613–617
Zager RA . Acute renal failure in the setting of bone marrow transplantation Kidney Int 1994 46: 1443–1458
Zager RA . Acute renal failure syndromes after bone marrow transplantation Adv Nephrol Necker Hosp 1997 27: 263–280
Cooper BW, Creger RJ, Soegiarso W et al. Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: effect of aminoglycoside therapy Am J Med 1993 94: 497–504
Herget-Rosenthal S, Uppenkamp M, Beelen D et al. Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation Nephron 2000 84: 136–141
Van Why SK, Friedman AL, Wei LJ, Hong R . Renal insufficiency after BMT in children Bone Marrow Transplant 1991 7: 383–388
Kist-van HJ, van-Zwet JM, Brand R et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT Bone Marrow Transplant 1998 22: 559–564
Patzer L, Hempel L, Ringelmann F et al. Renal function after conditioning therapy for bone marrow transplantation in childhood Med Pediatr Oncol 1997 28: 274–283
Kumar M, Kedar A, Neiberger RE . Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation Pediatr Hematol Oncol 1996 13: 375–379
Miralbell R, Bieri S, Mermillod B et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease J Clin Oncol 1996 14: 579–585
Berg U, Bolme P . Renal function in children following bone marrow transplantation Transplant Proc 1989 21: 3092–3094
Leblond V, Sutton L, Jacquiaud C et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation J Am Soc Nephrol 1995 6: 1661–1665
Tarbell NJ, Guinan EC, Niemeyer C et al. Late onset of renal dysfunction in survivors of bone marrow transplantation Int J Rad Oncol Biol Phys 1988 15: 99–104
Cohen EP . Radiation nephropathy after bone marrow transplantation Kidney Int 2000 58: 903–918
Shulman H, Striker G, Deeg HJ et al. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation – glomerular thromboses and tubular injury New Engl J Med 1981 305: 1392–1395
Skinner R, Cotterill SJ, Stevens MCG . Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study Br J Cancer 2000 82: 1636–1645
Rossi R, Pleyer J, Schafers P et al. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients Med Pediatr Oncol 1999 32: 177–182
Rossi R, Danzebrink S, Linnenburger K et al. Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples Acta Paed 1994 83: 1282–1286
Brodehl J, Gellissen K, Weber HP . Postnatal development of tubular phosphate reabsorption Clin Nephrol 1982 17: 163–171
Gretz N, Ecker TK, Kuhnle HF et al. Practicability of the inulin plasma single-shot clearance Contrib Nephrol 1990 81: 220–228
Lonnerholm G, Carlson K, Bratteby LE et al. Renal function after autologous bone marrow transplantation Bone Marrow Transplant 1991 8: 129–134
Womer RB, Pritchard J, Barratt TM . Renal toxicity of cisplatin in children J Ped 1985 106: 659–663
Brandt LJ, Broadbent V . Nephrotoxicity following carboplatin use in children: is routine monitoring of renal function necessary? Med Pediatr Oncol 1993 21: 31–35
Schwartz GH, Birn LP, Spitzer AL . The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents Pediatr Clin North Am 1987 34: 571–590
Jacobson P, West N, Hutchinson RJ . Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients Bone Marrow Transplant 1997 19: 481–485
Lawton CA, Cohen EP, Barberderus SW et al. Late renal dysfunction in adult survivors of BMT Cancer 1991 67: 2795–2800
Cohen EP, Lawton CA, Moulder JE et al. Clinical course of late-onset BMT nephropathy Nephron 1993 64: 626–635
Cohen EP, Piering WF, Kabler BC, Moulder JE . End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD Nephron 1998 79: 408–412
Kapinga E, Kardos G, van der Deure J, van Wijk JAE . Impaired renal function in children with renal tumors treated with nephrectomy, high dose chemotherapy and abdominal radiotherapy Pediatr Nephrol 2000 13: C40 (Abstr.)
Burk CD, Restaino I, Kaplan BS, Meadows AT . Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms’ tumour J Ped 1990 117: 331–335
Rossi R, Danzebrink S, Hillebrand D et al. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum Med Pediatr Oncol 1994 22: 27–32
Arikoski P, Komulainen J, Riikonen P et al. Reduced bone density at completion of chemotherapy for a malignancy Arch Dis Child 1999 80: 143–148
Arikoski P, Kroger H, Riikonen P et al. Disturbance in bone turnover in children with malignancy at completion of chemotherapy Med Pediatr Oncol 1999 33: 455–461
Clement De BA, Oostdijk W, Van Weel Sipman MH et al. Final height and hormonal function after bone marrow transplantation in children J Ped 1996 129: 544–550
Caron HN, Abeling N, van Gennip A et al. Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens Med Pediatr Oncol 1992 20: 42–47
Acknowledgements
This work was supported by a grant from the ‘Deutsche Krebshilfe–Mildred Scheel Stiftung’ M107/91/Br 1; No. 70482. We are grateful for their financial support. The authors also thank Mrs Isolde Bernhardt for her excellent technical assistance and data management, Dr Bellstedt for the amino acid analysis and the nursing staff of the HSCT unit for providing outstanding care of the patients.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patzer, L., Ringelmann, F., Kentouche, K. et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27, 319–327 (2001). https://doi.org/10.1038/sj.bmt.1702763
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702763
Keywords
This article is cited by
-
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant
Pediatric Nephrology (2022)
-
Teenagers and young adults with a past of allogenic hematopoietic stem cell transplantation are at significant risk of chronic kidney disease
Pediatric Nephrology (2022)
-
Risk factors for chronic kidney disease following acute kidney injury in pediatric allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation (2021)
-
Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children
Pediatric Nephrology (2014)
-
Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood
Pediatric Nephrology (2010)